Patent details

EP2269603 Title: Treatment of breast tumors with a rapamycin derivative in combination with exemestane.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2269603
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10174983.6
WO Publication Number:
EPO Publication Language:
English
SPC Number:
300769
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
18/02/2002
Grant date:
20/05/2015
EP Publication Date:
20/05/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/05/2015
EP B1 Publication Date:
20/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
18/08/2015
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/02/2022
Lapsed By Expiration Date:
Revocation Date:
30/10/2019
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
21/01/2019
 
 

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
21/01/2019
 
 

 

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

Historical Applicant/holder

From:
20/05/2015
To:
21/01/2019

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

From:
20/05/2015
To:
21/01/2019

 

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 WIEN, Austria (AT)

Domicile Holder

Name:
ir. H.A. Witmans c.s.
From:
20/05/2015
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Lane, Heidi
Address:
4105 BIEL-BENKEN, Switzerland (CH)

2

Name:
O'Reilly, Terence
Address:
4057 BASEL, Switzerland (CH)

3

Name:
Wood, Jeanette Marjorie
Address:
4105 BIEL-BENKEN BL, Switzerland (CH)

Licensee

Name:
Novartis Pharma B.V.
From:
10/05/2019
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
To:

Priority

1

Priority Patent Number:
0124957
Priority Date:
17/10/2001
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
0104072
Priority Date:
19/02/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/5685;
IPC or IDT classification:
A61K 31/337; A61K 31/436; A61K 31/475; A61K 31/502; A61K 31/555; A61K 31/704; A61K 31/7068; A61K 33/24; A61P 35/00; A61P 35/04;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
51/19
Publication date:
18/12/2019
Description:
Lapse or annulment

2

Bulletin Heading:
VB1
Journal edition number:
33/19
Publication date:
14/08/2019
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

3

Bulletin Heading:
MED
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Other communications

4

Bulletin Heading:
CO
Journal edition number:
14/19
Publication date:
03/04/2019
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
VB1
Journal edition number:
13/16
Publication date:
30/03/2016
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

6

Bulletin Heading:
VB1
Journal edition number:
12/16
Publication date:
23/03/2016
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

7

Bulletin Heading:
EP3
Journal edition number:
2015/36
Publication date:
02/09/2015
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

8

Bulletin Heading:
EP2
Journal edition number:
2015/22
Publication date:
27/05/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201951
Publication date:
18/12/2019
Description:
Revocation of the European patent

2

Issue number:
201933
Publication date:
14/08/2019
Description:
Opposition procedure started

3

Issue number:
201613
Publication date:
30/03/2016
Description:
Opposition procedure started

4

Issue number:
201612
Publication date:
23/03/2016
Description:
Opposition procedure started

5

Issue number:
201521
Publication date:
20/05/2015
Description:
Grant (B1)

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201900908A
Date Registered:
10/05/2019
License Effective Date:
10/05/2018
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis Pharma B.V.
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900116A
Date Registered:
21/01/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
14/02/2019
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
25/08/2015 Outgoing Correspondence Outgoing Letter 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_2_outgoingcorrespondence20150825.pdf
18/08/2015 Outgoing Correspondence Outgoing Letter 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_0_outgoingcorrespondence20150818.pdf
18/08/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_1_incomingcorrespondencepaper20150818.pdf
18/08/2015 Claims Translated claims 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_3_claims20150818.pdf
18/08/2015 Outgoing Correspondence Outgoing Letter 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_4_outgoingcorrespondence20150818.pdf
18/08/2015 Incoming Correspondence Paper Correspondence address details 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_5_incomingcorrespondencepaper20150818.pdf
18/08/2015 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /3/8/9/4/7/0510174983/docs/ep10174983.6_6_incomingcorrespondencepaper20150818.pdf